| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/19/1999 | CA2013573C Vaccines containing avirulent phop-type microorganisms |
| 01/19/1999 | CA1340327C Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 01/19/1999 | CA1340324C Plants with modified stamen cells |
| 01/19/1999 | CA1340322C Human papillomavirus type 41, its dna and the proteins encoded therefrom |
| 01/18/1999 | US6015565 Polynucleotides with sequences |
| 01/18/1999 | CA2237160A1 Gida1 |
| 01/18/1999 | CA2237147A1 Novel ratb |
| 01/18/1999 | CA2237049A1 Novel ratc |
| 01/18/1999 | CA2237043A1 Response regulator |
| 01/17/1999 | CA2237162A1 Novel glucose kinase |
| 01/16/1999 | CA2237784A1 Novel compounds |
| 01/15/1999 | CA2220849A1 A human pelota homolog |
| 01/14/1999 | WO1999001767A1 Reagent for detecting and monitoring viral infections |
| 01/14/1999 | WO1999001765A1 METHODS OF INHIBITING OR ENHANCING THE TGFβ-SMAD SIGNALING PATHWAY |
| 01/14/1999 | WO1999001582A1 Screening methods using an atpase protein from a virus of the flaviviridae family |
| 01/14/1999 | WO1999001565A1 Method for increasing secretion of proteins in eukaryotic host cells |
| 01/14/1999 | WO1999001562A1 Protein producing cell containing multiple copies of a desired gene and a screenable marker but no selection marker |
| 01/14/1999 | WO1999001557A1 Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy |
| 01/14/1999 | WO1999001555A1 Genes for niemann-pick type c disease |
| 01/14/1999 | WO1999001554A1 Mammalian secretory peptide-9 |
| 01/14/1999 | WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them |
| 01/14/1999 | WO1999001552A1 Fluorescent proteins as cell-type specific reporter |
| 01/14/1999 | WO1999001551A2 Novel inhibitor of cellular proliferation |
| 01/14/1999 | WO1999001550A1 A method for detection of alterations in msh5 |
| 01/14/1999 | WO1999001549A1 Transcriptional activators with graded transactivation potential |
| 01/14/1999 | WO1999001548A2 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
| 01/14/1999 | WO1999001474A1 Methods for the isolation of proteinase inhibitor proteins from potato tubers |
| 01/14/1999 | WO1999001473A2 Anti-bacterial methods and materials |
| 01/14/1999 | WO1999001471A1 Nik proteins, nucleic acids and methods |
| 01/14/1999 | WO1999001468A2 Vertebrate smoothened gene, gene products, and uses related thereto |
| 01/14/1999 | WO1999001466A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | WO1999001465A1 A senescence gene and its use in the treatment of cancer and other diseases |
| 01/14/1999 | WO1999001464A1 Componds and methods for treating and screening viral reactivation |
| 01/14/1999 | WO1999001153A1 Rio mamore hantavirus |
| 01/14/1999 | WO1999001146A1 Treatment of hemoglobin containing erythrocytes with nitric oxide |
| 01/14/1999 | WO1999001085A2 Autoimmune inner ear disease antigen and diagnostic assay |
| 01/14/1999 | WO1999001031A1 Methods for screening agents for inhibiting virulence in candida albicans using tup1 sequences |
| 01/14/1999 | WO1999001020A2 19 human secreted proteins |
| 01/14/1999 | WO1998050555A3 Enterococcus faecalis polynucleotides and polypeptides |
| 01/14/1999 | WO1998049314A3 ANTIGENIC COMPOSITION AND METHOD OF DETECTION FOR $i(HELICOBACTER PYLORI) |
| 01/14/1999 | WO1998049313A3 Characterization of granulocytic ehrlichia and methods of use |
| 01/14/1999 | WO1998045442A3 Secreted f-spondin homologs |
| 01/14/1999 | WO1998044102A3 Methods of modulating p33ing1 mediated apoptosis |
| 01/14/1999 | WO1998040498A3 Immunoadhesins and methods of production and use thereof |
| 01/14/1999 | WO1998039466A3 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 01/14/1999 | WO1998039436A3 Fibroblast growth factor mutein compositions and methods of use therefor |
| 01/14/1999 | WO1998039425A3 Vectors and methods for expression of mutant proteins |
| 01/14/1999 | WO1998038212A3 Chimeric polypeptides containing chemokine domains |
| 01/14/1999 | WO1998036081A3 Hybrid molecules for optically detecting changes in cellular microenvironments |
| 01/14/1999 | WO1998036067A3 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | WO1998035040A3 A single gene encoding aortic-specific and striated-specific muscle cell isoforms and uses thereof |
| 01/14/1999 | WO1998034952A3 Il-2 gene expression and delivery systems and uses |
| 01/14/1999 | WO1998021333A3 Nucleic acid encoding schwannomin-binding-proteins and products related thereto |
| 01/14/1999 | DE19729810A1 Mittel zur Sepsistherapie, seine Herstellung und seine Verwendung Means for sepsis therapy, its preparation and its use |
| 01/14/1999 | DE19729211A1 New semaphorin L proteins |
| 01/14/1999 | DE19727962A1 Fluoreszierende Proteine als zelltypspezifische Reporter Fluorescent proteins as cell type-specific reporter |
| 01/14/1999 | CA2687542A1 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
| 01/14/1999 | CA2296105A1 Novel inhibitor of cellular proliferation |
| 01/14/1999 | CA2295962A1 Reagent for detecting and monitoring viral infections |
| 01/14/1999 | CA2295933A1 Compounds and methods for treating and screening viral reactivation |
| 01/14/1999 | CA2295376A1 Anti-bacterial methods and materials |
| 01/14/1999 | CA2295310A1 Method for increasing secretion of proteins in eukaryotic host cells |
| 01/14/1999 | CA2295212A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | CA2295211A1 Autoimmune inner ear disease antigen and diagnostic assay |
| 01/14/1999 | CA2294705A1 19 human secreted proteins |
| 01/14/1999 | CA2294702A1 Mammalian secretory peptide-9 |
| 01/14/1999 | CA2294613A1 Methods for the isolation of proteinase inhibitor proteins from potato tubers |
| 01/14/1999 | CA2289453A1 Screening methods using an atpase protein from a virus of the flaviviridae family |
| 01/14/1999 | CA2264792A1 Treatment of hemoglobin containing erythrocytes with nitric oxide |
| 01/14/1999 | CA2236489A1 Novel compounds |
| 01/14/1999 | CA2225187A1 Xaf genes and polypeptides: methods and reagents for modulating apoptosis |
| 01/13/1999 | EP0890840A2 Assaying for collagen degradation in vivo |
| 01/13/1999 | EP0890647A2 PcrA, novel polypeptide of the DNA helicases family |
| 01/13/1999 | EP0890642A2 Retrovirus of the HIV-group and its application |
| 01/13/1999 | EP0890641A1 Novel IspA |
| 01/13/1999 | EP0890640A2 G-CSF analog compositions and methods |
| 01/13/1999 | EP0890639A2 BMP2-induced cDNA and its use |
| 01/13/1999 | EP0890638A2 Cancerous metastasis inhibitor |
| 01/13/1999 | EP0890578A2 Polynucleotides encoding human clock gene and their use |
| 01/13/1999 | EP0890361A1 Antitumor agent |
| 01/13/1999 | EP0890105A1 Methods for diagnosing and treating alzheimer's disease |
| 01/13/1999 | EP0889971A1 Phosphatase modulator |
| 01/13/1999 | EP0889969A1 Recombinant adenoviral vectors for human tumour gene therapy |
| 01/13/1999 | EP0889964A1 Soluble divalent and multivalent heterodimeric analogs of proteins |
| 01/13/1999 | EP0889961A2 Monocyte chemotactic protein-5 materials and methods |
| 01/13/1999 | EP0889959A1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease |
| 01/13/1999 | EP0889958A2 CANINE Beta 2- AND Beta 3-ADRENERGIC RECEPTORS AND USE THEREOF |
| 01/13/1999 | EP0889955A1 Recombinant phages |
| 01/13/1999 | EP0889906A1 Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
| 01/13/1999 | EP0889905A1 Cytokine antagonists and agonists |
| 01/13/1999 | EP0889904A2 The porcine heart fatty acid-binding protein encoding gene and methods to identify polymorphisms associated with body weight |
| 01/13/1999 | EP0889903A1 Broad spectrum antimicrobial peptides containing a tryptophan triplet and methods of use |
| 01/13/1999 | EP0889902A1 Antibiotic peptides from bovine milk |
| 01/13/1999 | EP0889900A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof |
| 01/13/1999 | EP0889899A1 Mycoplasma arthritidis superantigen |
| 01/13/1999 | EP0889737A1 Obesity protein compounds and formulations thereof |
| 01/13/1999 | EP0889735A1 Immunological methods for the treatment of gastrointestinal cancer |
| 01/13/1999 | EP0889734A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof |
| 01/13/1999 | EP0847278A4 Analogs of parathyroid hormone |
| 01/13/1999 | EP0724598B1 Growth factor heterodimers |